Literature DB >> 18832651

Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT.

Allison L Bayer1, Monica Jones, Jackeline Chirinos, Lesley de Armas, Taylor H Schreiber, Thomas R Malek, Robert B Levy.   

Abstract

Reconstitution of the recipient lymphoid compartment following hematopoietic cell transplantation (HCT) is typically delayed. The present studies investigated the residual host CD4(+)CD25(+)Foxp3(+) (Treg) compartment after several conditioning regimens, including T cell-depleted and T cell-replete HCT and observed (1) a small number of recipient Treg cells survived aggressive conditioning; (2) the surviving, that is, residual Tregs underwent marked expansion; and (3) recipient CD4(+)FoxP3(+) cells composed the majority of the Treg compartment for several months post-syngeneic HCT. Notably, residual Tregs also dominated the compartment post-HCT with T cell-depleted (TCD) major histocompatibility complex-matched allogeneic bone marrow but not following T cell-replete transplantations. The residual Treg cell compartment was functionally competent as assessed by in vitro lymphoid suppression and in vivo autoimmune disease transfer assay. These observations support the notion that functional host Tregs initially occupy a niche in lymphopenic transplantation recipients, undergo significant expansion, and contribute to the compartment for an extended period before donor-derived CD4(+)FoxP3(+) T cells eventually compose the majority of the compartment. In total, the findings suggest that the presence of host Tregs may be important to consider regarding elicitation of immune (eg, antitumor, vaccine) responses in recipients during the early post-transplant period involving autologous and certain allogeneic HCT regimens.

Entities:  

Mesh:

Year:  2008        PMID: 18832651      PMCID: PMC2628379          DOI: 10.1182/blood-2008-08-173179

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy.

Authors:  C L Mackall; R E Gress
Journal:  Immunol Rev       Date:  1997-06       Impact factor: 12.988

2.  Adoptive immunotherapy in canine chimeras.

Authors:  H J Kolb; W Günther; M Schumm; E Holler; W Wilmanns; S Thierfelder
Journal:  Transplantation       Date:  1997-02-15       Impact factor: 4.939

Review 3.  Restoration of T-cell homeostasis after T-cell depletion.

Authors:  C L Mackall; F T Hakim; R E Gress
Journal:  Semin Immunol       Date:  1997-12       Impact factor: 11.130

Review 4.  Immunological reconstitution following bone marrow transplantation.

Authors:  R Parkman; K I Weinberg
Journal:  Immunol Rev       Date:  1997-06       Impact factor: 12.988

5.  Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.

Authors:  Edmund K Waller; Cynthia R Giver; Hilary Rosenthal; Jyoti Somani; Amelia A Langston; Sagar Lonial; John D Roback; Jian-Ming Li; Mohammad S Hossain; Istvan Redei
Journal:  Blood Cells Mol Dis       Date:  2004 Nov-Dec       Impact factor: 3.039

6.  Apoptosis in bone marrow cells of mice with different p53 genotypes after gamma-rays irradiation in vitro.

Authors:  Y F Cui; P K Zhou; L B Woolford; B I Lord; J H Hendry; D W Wang
Journal:  J Environ Pathol Toxicol Oncol       Date:  1995       Impact factor: 3.567

7.  Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation.

Authors:  Alan M Hanash; Robert B Levy
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

8.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.

Authors:  C L Mackall; T A Fleisher; M R Brown; M P Andrich; C C Chen; I M Feuerstein; M E Horowitz; I T Magrath; A T Shad; S M Steinberg
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

9.  L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

Authors:  Patricia A Taylor; Angela Panoskaltsis-Mortari; Jessica M Swedin; Philip J Lucas; Ronald E Gress; Bruce L Levine; Carl H June; Jonathan S Serody; Bruce R Blazar
Journal:  Blood       Date:  2004-08-03       Impact factor: 22.113

10.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.

Authors:  H Suzuki; T M Kündig; C Furlonger; A Wakeham; E Timms; T Matsuyama; R Schmits; J J Simard; P S Ohashi; H Griesser
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

View more
  24 in total

1.  The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation.

Authors:  Paul A Cardenas; Yiming Huang; Suzanne T Ildstad
Journal:  Chimerism       Date:  2011-07-01

2.  Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant.

Authors:  Stephanie M Coomes; Carol A Wilke; Thomas A Moore; Bethany B Moore
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

3.  Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice.

Authors:  Narendiran Rajasekaran; Nan Wang; Phi Truong; Cornelia Rinderknecht; Claudia Macaubas; Georg F Beilhack; Judith A Shizuru; Elizabeth D Mellins
Journal:  Arthritis Rheum       Date:  2013-03

Review 4.  Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy.

Authors:  Isabela Pedroza-Pacheco; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

5.  Expansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation.

Authors:  Allison L Bayer; Jackeline Chirinos; Cecilia Cabello; Jing Yang; Takaji Matsutani; Thomas R Malek; Robert B Levy
Journal:  Eur J Immunol       Date:  2011-10-31       Impact factor: 5.532

6.  Hematopoietic progenitor cell regulation by CD4+CD25+ T cells.

Authors:  Maite Urbieta; Isabel Barao; Monica Jones; Roland Jurecic; Angela Panoskaltsis-Mortari; Bruce R Blazar; William J Murphy; Robert B Levy
Journal:  Blood       Date:  2010-03-03       Impact factor: 22.113

7.  Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.

Authors:  Casey O Lightbourn; Dietlinde Wolf; Sabrina N Copsel; Ying Wang; Brent J Pfeiffer; Henry Barreras; Cameron S Bader; Krishna V Komanduri; Victor L Perez; Robert B Levy
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

Review 8.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

9.  In situ activation and expansion of host tregs: a new approach to enhance donor chimerism and stable engraftment in major histocompatibility complex-matched allogeneic hematopoietic cell transplantation.

Authors:  Alwi Shatry; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2009-05-07       Impact factor: 5.742

10.  Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.

Authors:  Mareike Florek; Emanuela I Sega; Dennis B Leveson-Gower; Jeanette Baker; Antonia M S Müller; Dominik Schneidawind; Everett Meyer; Robert S Negrin
Journal:  Blood       Date:  2014-07-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.